Seer, Inc. (SEER)

Market Cap	95.35M -16.1%
Revenue (ttm)	16.58M +17.0%
Net Income	-73.60M
EPS	-1.28
Shares Out	56.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,206
Open	1.710
Previous Close	1.710
Day's Range	1.680 - 1.710
52-Week Range	1.640 - 2.410
Beta	1.60
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About SEER

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers ...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 124
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2025, Seer, Inc.'s revenue was $16.58 million, an increase of 16.99% compared to the previous year's $14.17 million. Losses were -$73.60 million, -15.01% less than in 2024.